c1_bannerpc-691.jpg c1_bannerph-226.jpg

Infection

Posaconazole Delayed-release Tablets
1-boshakang-meiguo.jpg
2-boshakang-aodaliya.jpg
3-boshakang-xinjiapo.jpg
  • 【Strength】100mg
  • 【Approved Regions】:US、China、 Australia、Singapore 、 Saudi Arabia、Canada

【Indication】

Prophylaxis of invasive Aspergillus and Candida Infections.


Oncology and Rheumatology

Olaparib Tablets
aolapali-431.jpg
  • 【Strength】100mg,150mg
  • 【Approved Regions】:China

【Indication】

Epithelial ovarian cancer、Fallopian tube cancer、Primary peritoneal cancer.


Exemestane Tablets
yiximeitan-869.jpg
  • 【Strength】25mg
  • 【Approved Regions】:China

【Indication】

Adjuvant treatment of postmenopausal women with estrogen-receptorpositive early breast cancer who have received two to three years oftamoxifen and are switched to Exemestane Tablets for completion of a total offive consecutive years of adjuvant hormonal therapy .

Treatment of advanced breast cancer in postmenopausal women whosedisease has progressed following tamoxifen therapy .


Tofacitinib Extended-release Tablets
tuofatibu-554.jpg
  • 【Strength】11mg,22mg
  • 【Approved Regions】:US(TA)、China

【Indication】Rheumatoid Arthritis、Psoriatic Arthritis、Ulcerative Colitis.


Gastroenterology and Metabolism

Mesalamine Delayed Release Tablets
meishalaqin-666.jpg
  • 【Strength】1.2g
  • 【Approved Regions】:US、China

【Indication】:

Induction and maintenance of remission in adult patients with mildly to moderately active ulcerative colitis.

Treatment of mildly to moderately active ulcerative colitis in pediatric patients weighing at least 24kg.


Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets
dageerjia-419.jpg
  • 【Strength】10mg/1000mg,5mg/1000mg,2.5mg/1000mg
  • 【Approved Regions】:China

【Indication】

This product, in combination with diet control and exercise, is indicated for improving blood sugar control in adult patients with type 2 diabetes who are suitable for treatment with dapagliflozin and metformin hydrochloride.


Sitagliptin and Metformin Hydrochloride Sustained-release Tablets
xigeerjia-142860pian-683.jpg
  • 【Strength】50mg/1000mg
  • 【Approved Regions】:China

【Indication】

Adults with type 2 diabetes who are receiving sitagliptin and metformin extended-release tablets.


Ursodeoxycholic ACID Capsules
xiongquyang-663.jpg
  • 【Strength】250mg
  • 【Approved Regions】:China

【Indication】

1. Cholesterol gallstones——the stone must be X-ray-transmissible and the gallbladder contraction function must be normal;

2. Cholestatic liver disease (such as primary biliary cirrhosis);

3. Bile reflux gastritis.


Neurology

Bupropion Hydrochloride Extended-release Tablets
1-anfeitatong-meiguo.jpg
2-anfeitatong-yiselie.jpg
  • 【Strength】150mg,300mg
  • 【Approved Regions】:US、China、Israel

【Indication】

Treatment of major depressive disorder (MDD)、Prevention of seasonal affective disorder (SAD).


Paroxetine Extended-release Tablets
paluoxiting-680.jpg
  • 【Strength】12.5mg,25mg
  • 【Approved Regions】:US、China

【Indication】

Major Depressive Disorder (MDD)、Panic Disorder (PD)、Social Anxiety Disorder (SAD)、Premenstrual Dysphoric Disorder (PMDD).


Pregabalin Extended-release Tablets
1-82.png
2-165.png
3-330.png
  • 【Strength】82.5 mg, 165 mg, 330 mg
  • 【Approved Regions】:US

【Indication】

Pregabalin extended-release tablets are indicated for the management of:

• Neuropathic pain associated with diabetic peripheral neuropathy (DPN)

• Postherpetic neuralgia (PHN)

Efficacy of pregabalin extended-release tablets has not been established for the management of fibromyalgia or as adjunctive therapy for adult patients with partial onset seizures.


Cardiology

Propafenone Hydrochloride Extended-release Capsules
1-puluopatong225mg-255.jpg
2-puluopatong325mg-919.jpg
3-puluopatong425mg-231.jpg
  • 【Strength】225mg,325mg,425mg
  • 【Approved Regions】:US

【Indication】

Propafenone hydrochloride extended-release capsules is an antiarrhythmic indicated to prolong the time to recurrence of symptomatic atrial fibrillation (AF) in patients with episodic (most likely paroxysmal or persistent) AF who do not have structural heart disease.


Nephrology

Sevelamer Carbonate Tablets
siweilamu-52.jpg
  • 【Strength】800mg
  • 【Approved Regions】:US、China、Philippines

【Indication】

Sevelamer carbonate tablets are a phosphate binder indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease on dialysis.


Shanghai Head Office

99 Haike Road, Bldg. 3, 1st Flr., Pudong District Shanghai 201210, P.R. China

Manufacturing Site in Jiangsu

No. 163 Zhuhai Road, Haimen Area, Nantong City, Jiangsu Province

Copyright © 2014-2022 SINOTHERAPEUTICS.COM ICP:13048014-1   Powered by Yongsy

Privacy Legal